Accelerator-based producer of medical and industrial radioisotopes
Nusano is building a particle accelerator facility in West Valley City, Utah to produce radioisotopes for medical and industrial use. Its stack pairs precision machining and design tools (Mastercam, SolidCAM, SolidWorks, ANSYS) with IBM Maximo and Epicor for asset and ERP control, plus a Kubernetes, Argo CD and Prometheus layer for control software. Engineering-led hiring centered on RF uptime and plant coverage points to a company moving from build-out into production.
Nusano is a privately held company headquartered in West Valley City, Utah, with 51-200 employees. It produces radioisotopes for applications that include cancer treatment, space exploration, nuclear waste reduction and alternative energy. Production is based on a proprietary ion source technology and a linear accelerator facility in Utah. The company draws on expertise in plasma physics, particle accelerators and quality assurance, and serves healthcare and industrial customers. All current hiring is in the United States.
Nusano produces medical and industrial radioisotopes using proprietary ion source technology and a linear accelerator-based production facility in West Valley City, Utah.
Nusano uses SolidWorks, Mastercam, SolidCAM, ANSYS Mechanical, IBM Maximo and Epicor, along with Python, C++, MATLAB, Docker, Kubernetes, GitLab CI/CD, Argo CD, Grafana, Prometheus and AWS.
Yes. Engineering leads Nusano's hiring, with additional roles in manufacturing, finance and operations, all based in the United States at mid and senior levels plus internships.
Other companies in the same industry, closest in size
Nusano's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.